Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura

被引:30
作者
Shojaiefard, A. [1 ]
Mousavi, S. A. [2 ]
Faghihi, S. H. [1 ]
Abdollahzade, S. [3 ,4 ]
机构
[1] Univ Tehran, Sch Med, Shariati Hosp, Dept Surg, Tehran, Iran
[2] Univ Tehran, Sch Med, Shariati Hosp, Dept Hematol & Oncol, Tehran, Iran
[3] Univ Tehran, Dept Surg, Shariati Hosp, Sch Med, Tehran, Iran
[4] Univ Tehran, SSRC, Tehran, Iran
关键词
D O I
10.1007/s00268-007-9399-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by destruction of opsonized platelets in the reticuloendothelial system, particularly the spleen, and by resulting low platelet counts. Splenectomy is the standard second-line treatment for patients with ITP who do not respond to corticosteroids. In the present study we determined predictive factors for the response of patients with ITP to splenectomy. Materials and Methods For thirty-one patients with ITP referred from the Hematology Department of Shariati Hospital, open surgical splenectomy was performed between February 2002 and December 2004. All potentially important variables of response were collected and analyzed to determine predictive parameters. Results Older patients (> 52) responded less positively than younger patients (< 52) to splenectomy (p < 0.01). Likewise, patients with a sustained remission after splenectomy had a significantly shorter interval of diagnosis of ITP to splenectomy (p < 0.05) and shorter duration of corticosteroid therapy before splenectomy (p < 0.05). Conclusions This study confirms that splenectomy is an effective treatment for patients with ITP. Our findings highlight age as the major predictive factor of long-term response to splenectomy in patients with ITP.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 42 条
[21]   Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications [J].
Kojouri, K ;
Vesely, SK ;
Terrell, DR ;
George, JN .
BLOOD, 2004, 104 (09) :2623-2634
[22]   Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses [J].
Kumar, S ;
Diehn, FE ;
Gertz, MA ;
Tefferi, A .
ANNALS OF HEMATOLOGY, 2002, 81 (06) :312-319
[23]   Clinicopathologic and prognostic features of chronic idiopathic hrombocytopenic purpura in adult Chinese patients: an analysis of 220 cases [J].
Leung, AYH ;
Chim, CS ;
Kwong, YL ;
Lie, AKW ;
Au, WY ;
Liang, R .
ANNALS OF HEMATOLOGY, 2001, 80 (07) :384-386
[24]   Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura [J].
Louwes, H ;
Lathori, QAZ ;
Vellenga, E ;
de Wolf, JTM .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (04) :430-434
[25]  
Moore M, 2000, AM SURGEON, V66, P955
[26]   The site of destruction of autologous In-111-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies [J].
Najean, Y ;
Rain, JD ;
Billotey, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :547-550
[27]  
Nugent Diane J, 2006, Hematology Am Soc Hematol Educ Program, P97
[28]   Factors predicting long-term responses to splenctomy in patients with idiopathic thrombocytopenic purpura [J].
Ojima, H ;
Kato, T ;
Araki, K ;
Okamura, K ;
Manda, R ;
Hirayama, I ;
Hosouchi, Y ;
Nishida, Y ;
Kuwano, H .
WORLD JOURNAL OF SURGERY, 2006, 30 (04) :553-559
[29]   Rituximab in the management of chronic immune thrombocytopenic purpura:: an effective and safe therapeutic alternative in refractory patients [J].
Peñalver, F ;
Jiménez-Yuste, V ;
Almagro, M ;
Alvarez-Larrán, A ;
Rodríguez, L ;
Casado, M ;
Gallur, L ;
Giraldo, P ;
Hernández, R ;
Menor, D ;
Rodríguez, M ;
Caballero, D ;
González, R ;
Mayans, J ;
Millán, I ;
Cabrera, J .
ANNALS OF HEMATOLOGY, 2006, 85 (06) :400-406
[30]   FATE OF THERAPY FAILURES IN ADULT IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].
PICOZZI, VJ ;
ROESKE, WR ;
CREGER, WP .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (05) :690-694